Skip to Main Content

File this under “What are friends for?”

A former head of statistics at Merrimack Pharmaceuticals has been accused of insider trading as part of a scheme in which he allegedly swapped the results of ongoing clinical trials with a friend who worked at a nearby biotech company, Akebia Therapeutics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!